Product on VINCIT LifeSciences
Vincit LifeSciences offers world class products and services for various critical illness and diseases. At Vincit LifeSciences, our purpose is to improve the quality of life of the communities we serve.
The products that fall in the Anti-Fungal range are as follows:
Contain Fluconazole 150mg capsule. Fluconazole is used to treat fungal infections, including yeast infections of the vagina, mouth, throat, esophagus (tube leading from the mouth to the stomach), abdomen (area between the chest and waist), lungs, blood, and other organs. Fluconazole is also used to treat meningitis (infection of the membranes covering the brain and spine) caused by fungus. Fluconazole is also used to prevent yeast infections in patients who are likely to become infected because they are being treated with chemotherapy or radiation therapy before a bone marrow transplant (replacement of unhealthy spongy tissue inside the bones with healthy tissue). Fluconazole is in a class of antifungals called triazoles. It works by slowing the growth of fungi that cause infection.

Mecanism of Action
fluconazole inhibits the fungal cytochrome P450 enzyme 14α-demethylase. Mammalian demethylase activity is much less sensitive to fluconazole than fungal demethylase. This inhibition prevents the conversion of lanosterol to ergosterol, an essential component of the fungal cytoplasmic membrane, and subsequent accumulation of 14α-methyl sterols. Fluconazole is primarily fungistatic; however, it may be fungicidal against certain organisms in a dose-dependent manner, specifically Cryptococcus

Pharmacokinetic Data
Bioavaibility
:
90 %
Protein Binding
:
11 to 12 %
Metabolism
:
Hepatic
Half Life
:
In between 20 to 38 hours
Excretion
:
Renal excretion & Unchanged in Urine
 


Indications
  • Syatemic & Mucosal Candidiasis
  • Vulvo-Vaginal Candidiasis
  • Coccidioidomycosis
  • Diabetic skin conditions
  • Tinea Corporis, Tinea Cruris, Tinea Pedis
  • Onychomycosis
  • Cryptococcal meningitis
 


Dose
  • Varies with indication and between patient groups
  • ranging from: A two-week course of VISOLVE 150 mg/day for vulvo-vaginal candidiasis
  • To VISOLVE 150/300mg once weekly for resistant skin infections or some prophylactic indications